July 10, 2021
by Alex Brown
Biopharma insight
The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging …
May 24, 2021
by Irina Bilous
Biopharma insight
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even …
Aug. 18, 2020
by Ivan Kondratov
Biopharma insight
Recently my favorite website ENDPOINTSNEWS published a rating of key players in the ongoing COVID-19 vaccine race. Compared to many …
May 22, 2020
by Andrii Buvailo
Interview
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a world leader in developing allogeneic (off-the-shelf) cellular medicines, just announced that the first COVID-19 infected …
Feb. 9, 2020
by Irina Bilous
Biopharma insight
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
Feb. 6, 2020
by Caroline Green
Biopharma insight
In a recent study published in Nature Communications, scientists from Cornell University made new findings in common and fatal gastric …
Dec. 11, 2017
by Alfred Ajami
Biopharma insight
Immunotherapies are hot property. Immuno-oncology is the crown jewel. But the road to riches, and more importantly cancer cures, is …
Nov. 13, 2017
by Alfred Ajami
Biopharma insight
Consensus seems universal and the news about it flows literally by the minute over gene editing as a future therapy, …
Aug. 21, 2017
by BiopharmaTrend
Undefined
This is an interview with Niels Iversen Møller, a CEO, and Co-founder of Evaxion Biotech -- an immuno-informatics biotech from …
Oct. 25, 2016
by Andrii Buvailo
Biopharma insight
To date, nature has been the best teacher for drug discovery scientists, especially for those who develop antimicrobial drugs. Lately, …
June 24, 2016
by Andrii Buvailo
Biopharma insight
A billionaire Sean Parker, known as a founder of Facebook and Napster, has steeply entered Life Sciences industry to fund …